Seminars in Hematology : Impact Factor & More
eISSN: 1532-8686pISSN: 0037-1963
Share this on:
Key Metrics
CiteScore 
6.8
H-Index
100
Impact Factor
< 5
SJR
Q1Hematology
SNIP
1.18
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Seminars in Hematology
Seminars in Hematology Journal Specifications
| Overview | |
| Publisher | W B SAUNDERS CO-ELSEVIER INC |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1964 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Seminars in Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Seminars in Hematology
The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.
- 17 Jul 2026
- Seminars in hematology
Germline predisposition in myeloproliferative neoplasms.
- 3 Jul 2026
- Seminars in hematology
Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.
- 1 Jul 2026
- Seminars in hematology
Alloimmunization in sickle cell disease: Addressing an ongoing clinical challenge.
- 5 Jun 2026
- Seminars in hematology
Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies
- 3 Jun 2026
- Seminars in hematology
Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.
- 3 Jun 2026
- Seminars in hematology
The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.
- 17 Jul 2026
- Seminars in hematology
Germline predisposition in myeloproliferative neoplasms.
- 3 Jul 2026
- Seminars in hematology
Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.
- 1 Jul 2026
- Seminars in hematology
Alloimmunization in sickle cell disease: Addressing an ongoing clinical challenge.
- 5 Jun 2026
- Seminars in hematology
Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies
- 3 Jun 2026
- Seminars in hematology
Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.
- 3 Jun 2026
- Seminars in hematology
FAQs on Seminars in Hematology
How long has Seminars in Hematology been actively publishing? 
What is the publishing frequency of Seminars in Hematology?
How many articles did Seminars in Hematology publish last year?
What is the eISSN & pISSN for Seminars in Hematology?
What is Citescore for Seminars in Hematology?
What is the H Index for Seminars in Hematology ?
What is SNIP score for Seminars in Hematology?
What is the SJR for Seminars in Hematology?
Who is the publisher of Seminars in Hematology?
